Tag: Dupilumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Dupilumab

FDA Approves Dupilumab for Chronic Spontaneous Urticaria Uncontrolled by Antihistamines

Added to Collection on: 2025-04-18 18:15:08

Tags for this article:

Type I hypersensitivity
Antiasthmatic drugs
Dupilumab
Sanofi
Atopic dermatitis
Hives
Regeneron Pharmaceuticals
Chronic spontaneous urticaria
Itch
Asthma
Eosinophilic esophagitis
Dermatitis
United States

Click the tags to see associated articles and topics

View Article Details
Dupixent bests Xolair in first head-to-head respiratory trial: 4 takeaways

Added to Collection on: 2025-06-16 09:22:37

Tags for this article:

Antiasthmatic drugs
Dupilumab
Sanofi
Asthma
Prurigo nodularis
Regeneron Pharmaceuticals
Omalizumab
Eosinophilic esophagitis
Atopic dermatitis
Immunoglobulin E
Nasal polyp
Sinusitis
Xolair

Click the tags to see associated articles and topics

View Article Details
Effectiveness and Safety of Dupilumab Monotherapy in Japanese Patients With Chronic ...

Added to Collection on: 2025-08-30 20:38:03

Tags for this article:

Antiasthmatic drugs
Dupilumab
Sanofi
Rhinology
Otorhinolaryngology
Sinusitis
Nasal polyp
Polyp
Corticosteroid
Aspirin-exacerbated respiratory disease

Click the tags to see associated articles and topics

View Article Details
Global Chronic Inducible Urticaria Market Set to Grow with Advances in Biologics and ...

Added to Collection on: 2025-08-31 12:35:59

Tags for this article:

Antiasthmatic drugs
Monoclonal antibodies
Hives
Type I hypersensitivity
Dupilumab
Omalizumab
Immunoglobulin E
Biopharmaceutical
Icos
PDE4 inhibitor
Ligelizumab
Autoimmune urticaria

Click the tags to see associated articles and topics

View Article Details
Sanofi's touted eczema drug hits study goal, but data fall short of expectations

Added to Collection on: 2025-09-05 00:08:56

Tags for this article:

Sanofi
CAC 40
Pharmaceutical companies
Regeneron Pharmaceuticals
Dupilumab
Amgen
CD134

Click the tags to see associated articles and topics

View Article Details
REGN Loses 21.1% Year to Date: Buy, Sell or Hold the Sock? - TradingView

Added to Collection on: 2025-09-15 15:32:00

Tags for this article:

Sanofi
Regeneron Pharmaceuticals
Aflibercept
Macular edema
Bayer
Dupilumab
Cemiplimab
Central retinal vein occlusion
Priority review
Eylea
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
Douglas DiRuggiero, DMSc, MHS, PA-C, on the Evolving Landscape of Dermatologic Care

Added to Collection on: 2025-09-21 18:04:47

Tags for this article:

Autoimmune diseases
Dermatology
Psoriasis
Hidradenitis suppurativa
Pemphigoid
Bullous pemphigoid
Dupilumab
Douglas DiRuggiero
Ted Rosen
Nashville

Click the tags to see associated articles and topics

View Article Details
Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with ...

Added to Collection on: 2025-09-22 04:59:28

Tags for this article:

Sanofi
Monoclonal antibodies
Chronic lower respiratory diseases
Anti-asthmatic agents
CAC 40
Dupilumab
Regeneron Pharmaceuticals
Atopic dermatitis
Prurigo nodularis
Eosinophilic esophagitis
Asthma
Casirivimab/imdevimab
REGENERON GENETICS CENTER

Click the tags to see associated articles and topics

View Article Details
Small biotechs could win big with Sanofi's $625m VC play - BioXconomy

Added to Collection on: 2025-09-29 18:42:05

Tags for this article:

Sanofi
CAC 40
Dupilumab
Sanofi Ventures

Click the tags to see associated articles and topics

View Article Details
Evommune files for IPO to advance immune drug work | BioPharma Dive

Added to Collection on: 2025-10-10 18:43:46

Tags for this article:

Type I hypersensitivity
Anti-asthmatic agents
Hives
Immunology
Atopic dermatitis
Chronic spontaneous urticaria
Dupilumab
Omalizumab
Antihistamine
Inflammation
Mast cell
Immunoglobulin E
Evommune

Click the tags to see associated articles and topics

View Article Details
Book a Demo